The most recent advances in developing vaccines against malaria;Avances más recientes en el desarrollo de vacunas contra la malaria

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 17, Issue 2, 2005, Pages 142-146

  Rojas Rivero, Lázara ^a   Sarracent Pérez, Jorge ^a   Fonte Galindo, Luis ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

Falciparum; Malaria; Malaria vaccines

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; MALARIA VACCINE; POLYPEPTIDE; RTS S AS02A VACCINE; UNCLASSIFIED DRUG;

DISEASE TRANSMISSION; MALARIA; VACCINATION;

CLINICAL TRIAL; DISEASE TRANSMISSION; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; ENDEMIC DISEASE; HEALTH CARE ORGANIZATION; HUMAN; IMMUNOGENICITY; MALARIA; MOZAMBIQUE; PLASMODIUM FALCIPARUM; REVIEW; SIDE EFFECT; VACCINE PRODUCTION; WESTERN HEMISPHERE; ARTICLE; MEDICAL RESEARCH;

PLASMODIUM FALCIPARUM;

BIOMEDICAL RESEARCH; HUMANS; MALARIA; MALARIA VACCINES;

EID: 14844322811     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1020-49892005000200013     Document Type: Review

References (17)

1. Snow RW, Craig M, Deichmann U, Marsh K. Estimating mortality, morbidity, and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ. 1999;77:624-40.
2. Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet. 2004;364:1411-20.
3. a Conferencia Sanitaria Panamericana, septembre 23-26 de 2002; Washington, D.C. Washington, D.C.: OPS; 2002. (CSP62/INF/3 [Esp]).
4. Nussenzweig RS, Vanderberg J, Most H, Orton C. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature. 1967;216:160-2.
5. Ballou WR, Arévalo-Herrera M, Carucci D, Richie TL, Corradin G, Diggs C, et al. Update on the clinical development of candidate malaria vaccines. Am J Trop Med Hyg. 2004;71:239-47.
6. Good MF. Towards a blood-stage vaccine for malaria: are we following all the leads? Nat Rev Immunol. 2001;1:117-25.
7. Carter R, Mendis KN, Miller LH, Molineaux L, Saul A. Malaria transmission-blocking vaccines-how can their development be supported? Nature Med. 2000;6:241-4.
8. Gozar MM, Muratova O, Keister DB, Kensil CR, Price VL, Kaslow DC. Plasmodium falciparum: immunogenicity of alum-adsorbed clinical-grade TBV25-28, a yeast-secreted malaria transmission-blocking vaccine candidate. Exp Parasitol. 2001;97:61-9.
9. Hoffmann SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002;185:1155-64.
10. Gordon DM, McGovern TW, Krzych U, Cohen JC, Schneider I, LaChance R, et al. Safety immunogenicity and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J Infect Dis. 1995;171:1576-85.
11. + T cells producing IFN γ J Immunology. 2003;171:6961-7.
12. Bojang KA, Milligan PJ, Finder M, Vigneron L, Alloueche A, Kester KE, et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in the Gambia: a randomised trial. Lancet. 2001;358: 1927-34.
13. Patarroyo ME, Amador R, Calvijo P, Moreno A, Guzmán F, Romero P, et al. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature. 1988;332:158-61.
14. Valero MB, Amador LR, Galindo C, Figueroa J, Bello MS, Murillo LA, et al. Vaccination with SPf66, chemically synthesized vaccine against P falciparum malaria in Colombia. Lancet. 1993;341: 705-10.
15. Alonso PL, Smith T, Schellenberg JRMA, Masanja H, Mwankuysre S, Urassa H, et al. Ramdomised trial of efficacy of SPf66 vaccine against P falciparum malaria in children in Southern Tanzania. Lancet. 1994;344:1175-81.
16. D'Alexandro U, Leach A, Drakeley CI, Bennett S, Olaleye BO, Fegan GW, et al. Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet. 1995;346: 462-67.
17. Nosten F, Luxemburger C, Kyle DE, Ballou WR, Wittes J, Wah E, et al. Ramdomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in north-western Thailand. Lancet. 1997;346:701-7.